165 related articles for article (PubMed ID: 38233757)
1. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.
You X; Dong Y; Wang J; Cheng Y; Jia Y; Zhang X; Wang J
BMC Cancer; 2024 Jan; 24(1):99. PubMed ID: 38233757
[TBL] [Abstract][Full Text] [Related]
2. Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases.
Black C; Feng A; Bittinger S; Quinn M; Neesham D; McNally O
Int J Gynecol Cancer; 2016 Jan; 26(1):133-40. PubMed ID: 26588230
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
[No Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.
Wilkinson-Ryan I; Frolova AI; Liu J; Stewart Massad L; Thaker PH; Powell MA; Mutch DG; Hagemann AR
Int J Gynecol Cancer; 2015 Jan; 25(1):63-8. PubMed ID: 25365590
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinoma.
Kilic F; Ersak B; Cakir C; Yuksel D; Kilic C; Korkmaz V; Tokgozoglu N; Toptas T; Boran N; Kimyon Comert G; Ureyen I; Tasci T; Moraloglu Tekin O; Ustun Y; Turan T
J Obstet Gynaecol Res; 2024 Jan; 50(1):86-94. PubMed ID: 37854000
[TBL] [Abstract][Full Text] [Related]
6. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors of Uterine Serous Carcinoma-A Multicenter Study.
Zhong X; Wang J; Kaku T; Wang Z; Li X; Wei L
Int J Gynecol Cancer; 2018 Jul; 28(6):1138-1144. PubMed ID: 29621127
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy in patients with stage IVB uterine serous carcinoma: a Turkish multicentric study.
Unsal M; Kilic C; Cakir C; Kilic F; Ersak B; Karakas S; Tokgozoglu N; Varli B; Oktar O; Kimyon Comert G; Ozdemir IA; Boran N; Toptas T; Ureyen I; Korkmaz V; Taskin S; Moraloglu Tekin O; Ustun Y; Tasci T; Ortac F; Turan T
J Obstet Gynaecol; 2023 Dec; 43(1):2151355. PubMed ID: 36503383
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: A multi-institutional cohort study.
Erickson BK; Najjar O; Damast S; Blakaj A; Tymon-Rosario J; Shahi M; Santin A; Klein M; Dolan M; Cimino-Mathews A; Buza N; Ferriss JS; Stone RL; Khalifa M; Fader AN
Gynecol Oncol; 2020 Oct; 159(1):17-22. PubMed ID: 32709539
[TBL] [Abstract][Full Text] [Related]
10. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
11. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
[TBL] [Abstract][Full Text] [Related]
12. Role of surgical staging and adjuvant treatment in uterine serous carcinoma.
Frey MK; Bashir S; Ward NM; Hensel KJ; Caputo TA; Holcomb KM; Baergen R; Gupta D
Eur J Gynaecol Oncol; 2013; 34(5):453-6. PubMed ID: 24475582
[TBL] [Abstract][Full Text] [Related]
13. The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study.
Cakir C; Kilic F; Kilic C; Tokgozoglu N; Ersak B; Ayhan S; Akar S; Yuksel D; Korkmaz V; Boran N; Toptas T; Kimyon Comert G; Ureyen I; Tasci T; Turkmen O; Moraloglu Tekin O; Ustun Y; Turan T
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102063. PubMed ID: 33453448
[TBL] [Abstract][Full Text] [Related]
14. A 4-gene signature predicts prognosis of uterine serous carcinoma.
Chen H; Li L; Qin P; Xiong H; Chen R; Zhang M; Jiang Q
BMC Cancer; 2021 Feb; 21(1):154. PubMed ID: 33579221
[TBL] [Abstract][Full Text] [Related]
15. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
Fader AN; Java J; Tenney M; Ricci S; Gunderson CC; Temkin SM; Spirtos N; Kushnir CL; Pearl ML; Zivanovic O; Tewari KS; O'Malley D; Hartenbach EM; Hamilton CA; Gould NS; Mannel RS; Rodgers W; Walker JL
Gynecol Oncol; 2016 Dec; 143(3):460-465. PubMed ID: 27743738
[TBL] [Abstract][Full Text] [Related]
16. Uterine serous carcinoma: a comparison of therapy for advanced-stage disease.
Gehrig PA; Morris DE; Van Le L
Int J Gynecol Cancer; 2004; 14(3):515-20. PubMed ID: 15228426
[TBL] [Abstract][Full Text] [Related]
17. Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center.
Ditto A; Leone Roberti Maggiore U; Lopez S; Martinelli F; Bogani G; Lo Vullo S; Brusadelli C; Paolini B; Ducceschi M; Mantiero M; Chiappa V; Signorelli M; Evangelista M; Mariani L; Raspagliesi F
Eur J Surg Oncol; 2022 Jan; 48(1):268-274. PubMed ID: 34753617
[TBL] [Abstract][Full Text] [Related]
18. Impact of tubal ligation on routes of dissemination and overall survival in uterine serous carcinoma.
Ayeni TA; Bakkum-Gamez JN; Mariani A; McGree ME; Weaver AL; AlHilli MM; Martin JR; Keeney GL; Dowdy SC; Podratz KC
Gynecol Oncol; 2013 Jan; 128(1):71-76. PubMed ID: 23127971
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
[TBL] [Abstract][Full Text] [Related]
20. Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis.
Tutkun Kilinc EC; Korkmaz V; Yalcin HR
J Obstet Gynaecol; 2022 Nov; 42(8):3725-3730. PubMed ID: 36927276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]